Sponsor

Alentis Therapeutics AG

Clinical research sponsor

Published trials2

Recruiting shown2

Roles1

SourceClinicalTrials.gov

Clinical trials

2 shown

A Study to Investigate ALE.P03 as Monotherapy in Adult Patients With Selected Advanced or Metastatic CLDN1+ Solid TumorsNCT07169734 · lead sponsor · 2025-08-26

RECRUITING

A Study to Investigate ALE.P02 as Monotherapy in Adult Patients With Selected CLDN1+ Solid TumorsNCT06747585 · lead sponsor · 2024-12-16

RECRUITING

Sponsor roles

lead sponsor2

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.